Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option.

Oncogene · 2018 · PMC6160395 · PMID 29855615

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

borderline significantp = 0.087so close (0.05 < p ≤ 0.1)

Nevertheless, if PVR was excluded from the multivariate cox regression, high PVRL2 expression represented a negative prognostic marker for RFS ( p = 0.017), and had a borderline significant negative impact on OS ( p = 0.087; see Table 1 for hazard ratios).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.